Susan M. Parkin
University of Bradford
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Susan M. Parkin.
Biochimica et Biophysica Acta | 2002
Paula Urquhart; Susan M. Parkin; Julia Sarah Rogers; John Anthony Bosley; Anna Nicolaou
The effects of a conjugated linoleic acid (CLA) mixture of single isomers (50:50, w/w, cis9,trans11:trans10,cis12) and the individual isomers on (a) the production of resting and calcium ionophore stimulated (14)C-eicosanoids and (b) the incorporation of (14)C-arachidonic acid (AA) into membrane phospholipids of human saphenous vein endothelial cells were investigated. The CLA mixture and the individual isomers were found to inhibit resting production of (14)C-prostaglandin F(2a) by 50, 43 and 40%, respectively. A dose dependent inhibition of stimulated (14)C-prostaglandins was observed with the CLA mixture (IC(50) 100 microM). The cis9,trans11 and trans10,cis12 (50 microM) isomers individually inhibited the overall production of stimulated (14)C-prostaglandins (between 35 and 55% and 23 and 42%, respectively). When tested at a high concentration (100 microM), cis9,trans11 was found to inhibit eicosanoid production in contrast to trans10,cis12 that caused stimulation. The overall degree of (14)C-AA incorporation into membrane phospholipids of the CLA (mixture and individual isomers) treated cells was found to be lower than that of control cells and the cis9,trans11 isomer was found to increase the incorporation of (14)C-AA into phosphatidylcholine. Docosahexaenoic acid, eicosapentaenoic acid and linoleic acid did not alter the overall degree of incorporation of (14)C-AA. The results of this study suggest that both isomers inhibit eicosanoid production, and although trans10,cis12 exhibits pro-inflammatory activity at high concentrations, the CLA mixture maintains its beneficial anti-inflammatory action that contributes to its anti-carcinogenic and anti-atherogenic properties.
Annals of Clinical Biochemistry | 2003
S. Dalal; Susan M. Parkin; Shervanthi Homer-Vanniasinkam; Anna Nicolaou
Background: Hyperhomocysteinaemia is an independent risk factor in the development of cardiovascular disease. Although homocysteine has been shown to affect endothelial cell function, the mechanisms by which it induces disease states are still poorly understood. Here, we report the ability of homocysteine to influence inflammatory cytokine/chemokine production by human saphenous vein endothelial cells, peripheral blood monocytes and monocyte-derived macrophages. Methods: Human saphenous vein endothelial cells, peripheral blood monocytes and monocyte-derived macrophages were treated with homocysteine (0.1-5 mmol/L) for 4 and/or 24h. Tumour necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6 and IL-8 production was measured in the cell culture media using commercially available enzyme-linked immunosorbent assays. Results: Interleukin-6 production by human saphenous vein endothelial cells was significantly stimulated following a 24-h treatment with homocysteine, whilst IL-8 concentrations were inhibited after both 4- and 24-h treatments. Homocysteine was also found to stimulate IL-1β production by human peripheral blood monocytes and TNF-α production by monocyte-derived macrophages. Conclusions: Overall, results from this study suggest that homocysteine alters the profile of cytokine/chemokine production by endothelial cells and macrophages. This altered profile may be important in the inflammatory events that initiate or enhance the development of atherosclerotic lesions.
Annals of the New York Academy of Sciences | 1994
J. N. Crinnion; S. Homer‐Vanniasinkam; Susan M. Parkin; M. J. Gough
Thromboxane A2, leukotriene B4, and NE are all released from ischemic muscle during reperfusion. Thromboxane A2 levels peaked at 10 min and this potent vasoconstrictor may be responsible for low reflow. Neutrophil elastase levels did not rise until 240 min of reperfusion, following that of leukotriene B4 at 120 min, indicating that neutrophil recruitment and activation is a relatively late event following revascularization. In conclusion, it would appear that endothelial factors have a significant role in the vasomotor changes that account for low reflow. Equally altered neutrophil function almost certainly contributes to the final development of reperfusion injury.
Biochemical and Biophysical Research Communications | 2007
Karin U. Schallreuter; Nicholas C.J. Gibbons; Souna M. Elwary; Susan M. Parkin; John M. Wood
Journal of Investigative Dermatology | 1995
Valerie A. Randall; Michael Nutbrown; Neil S. Calver; Susan M. Parkin; Susan P.MacDonald Hull; W.J. Cunliffe
Prostaglandins Leukotrienes and Essential Fatty Acids | 2001
Paula Urquhart; Susan M. Parkin; Anna Nicolaou
Biochemical Society Transactions | 1997
Yaw-Chyn Lim; Michael J. Gough; Shervanthi Homer-Vanniasinkam; Susan M. Parkin
Annals of the New York Academy of Sciences | 1994
J. N. Crinnion; S. Homer‐Vanniasinkam; R. Hatton; Susan M. Parkin; M. J. Gough
Journal of Dermatological Science | 1993
N.S. Calver; Susan M. Parkin; S. Macdonald Hull; W.J. Cunliffe; Valerie A. Randall
In: Advances in Prosraglandin and Leukotriene Research: Basic Science and New Clinical Applications. ; 04 Jun 2000-08 Jun 2000; Florence. 2000. | 2000
Anna Nicolaou; Paula Urquhart; Susan M. Parkin